Symetryx Corp

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 44% 8.2% 15.1%
Success rate 92% 68% 82%
Transactions
7 14% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 84%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Symetryx Corp's trades of NeuBase Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
242.36
Quantity 78,536 +33.8%
Value US$4,585,082
Transaction date
Sale
Price
113.94
Quantity 39,416 -33.4%
Value US$3,824,842
Transaction date
Sale
Price
244.25
Quantity 37,364 +22.3%
Value US$4,730,845
Transaction date
Purchase
Price
0.98
Quantity 61,076 +9.9%
Value US$59,732
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-18 2023-09-18
S Sale
78,536 +33.8%
242.36
US$4,585,082 		78,536 +33.8% 242.36 US$4,585,082
2023-09-18 2023-09-15
S Sale
39,416 -33.4%
113.94
US$3,824,842 		39,416 -33.4% 113.94 US$3,824,842
2023-09-18 2023-09-14
S Sale
37,364 +22.3%
244.25
US$4,730,845 		37,364 +22.3% 244.25 US$4,730,845
2023-09-11 2023-09-11
S Sale
3,376 -0.7%
1.44
US$4,861 		3,376 -0.7% 1.44 US$4,861
2023-09-11 2023-09-08
S Sale
128,847 -21.3%
1.53
US$197,136 		128,847 -21.3% 1.53 US$197,136
2023-09-11 2023-09-07
S Sale
74,852 -11.0%
1.80
US$134,734 		74,852 -11.0% 1.80 US$134,734
2023-09-07 2023-09-01
B Purchase
61,076 +9.9%
0.98
US$59,732 		61,076 +9.9% 0.98 US$59,732